Methylphenidate reduces energy intake and dietary fat intake in adults: a mechanism of reduced reinforcing value of food?-Reference-Cited by-同舟云学术

Methylphenidate reduces energy intake and dietary fat intake in adults: a mechanism of reduced reinforcing value of food?

Published:2007-08-01 Issue:2 Volume:86 Page:308-315
ISSN:0002-9165
Container-title:The American Journal of Clinical Nutrition
language:en
Short-container-title:

Author:

Goldfield Gary S¹,Lorello Claudio¹,Doucet Éric¹

Affiliation:

1. From Mental Health Research, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON (GSG); the School of Human Kinetics (GSG, CL, and ED), Department of Paediatrics (GSG), University of Ottawa, Ottawa, ON; and the Department of Psychology, Carleton University, Ottawa, ON (GSG)

Publisher

Oxford University Press (OUP)

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://academic.oup.com/ajcn/article-pdf/86/2/308/23916502/znu00807000308.pdf

Reference61 articles.

1. Food reward: brain substrates of wanting and liking;Berridge;Neurosci Biobeh Rev,1996

2. The involvement of nucleus accumbens dopamine in appetitive and aversive motivation;Salamone;Behav Brain Res,1994

3. The reinforcing value of food in obese and non-obese women;Saelens;Appetite,1996

4. Behavioral economics of obesity: food intake and energy expenditure;Epstein,2000

5. The performance of obese and normal size children on a delay of gratification task;Johnson;Addict Behav,1978

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy;International Journal of Molecular Sciences;2024-07-27

2. Effects of 2 months of methylphenidate on energy expenditure in individuals with obesity: A randomized, double‐blind, placebo‐controlled pilot study;Physiological Reports;2024-06

3. Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes;Biomedicines;2023-11-07

4. Craniopharyngioma—An update on metabolic and cognitive complications and new therapy;Journal of Internal Medicine;2023-07-09

5. Pharmacotherapy of obesity: an update on the available medications and drugs under investigation;eClinicalMedicine;2023-04